BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1 AND Diagnosis
54 results:

  • 1. The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma.
    Takeda N; Makise N; Kageyama H; Takahashi T; Katoh H; Odaka A; Oikawa M; Sugiyama T; Kawana H; Araki A; Kinoshita H; Hagiwara Y; Kamoda H; Yonemoto T; Itami M
    Virchows Arch; 2024 Mar; 484(3):533-538. PubMed ID: 38483612
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Biphenotypic Sinonasal Sarcoma with a Novel pax7::PPARGC1 Fusion: Expanding the Spectrum of Gene Fusions Beyond the PAX3 Gene.
    Bhele S; Chrisinger JSA; Farrell NF; Van Tine BA; Raptis CA; Chernock RD
    Head Neck Pathol; 2023 Sep; 17(3):826-831. PubMed ID: 37378830
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
    de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
    JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
    Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
    Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
    J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
    Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ewing and Ewing-like sarcomas: A morphological guide through genetically-defined entities.
    Yoshida A
    Pathol Int; 2023 Jan; 73(1):12-26. PubMed ID: 36484765
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Does pax7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
    Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
    Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and pax7-FOXO1].
    Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
    Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. PAX3-NCOA1 alveolar rhabdomyosarcoma of the tongue: A rare entity with challenging diagnosis and management.
    Di Carlo D; Chargari C; Scoazec JY; Cotteret S; Felix A; Moalla S; Temam S; Minard-Colin V
    Pediatr Blood Cancer; 2021 Nov; 68(11):e29288. PubMed ID: 34424607
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Adding Perplexity to Rarity: Diffuse S100-Protein and SOX10 Expression in a Molecularly Confirmed pax7-Positive Primary Cutaneous Ewing Sarcoma.
    Parra O; Thuraisingam R; Baker ML; Kerr DA; Linos K
    Am J Dermatopathol; 2021 Dec; 43(12):984-989. PubMed ID: 34132666
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Changes in FXR1 expression after Chemotherapy for Rhabdomyosarcoma.
    Xu MC; Ghani MO; Apple A; Chen H; Whiteside M; Borinstein SC; Correa H; Lovvorn HN
    J Pediatr Surg; 2021 Jun; 56(6):1148-1156. PubMed ID: 33736876
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Rhabdomyosarcoma: From Obscurity to Clarity in diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
    Parham DM; Giannikopoulos P
    Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
    Heske CM; Chi YY; Venkatramani R; Li M; Arnold MA; Dasgupta R; Hiniker SM; Hawkins DS; Mascarenhas L
    Cancer; 2021 Mar; 127(6):946-956. PubMed ID: 33216382
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle markers.
    Michal M; Rubin BP; Agaimy A; Kosemehmetoglu K; Rudzinski ER; Linos K; John I; Gatalica Z; Davis JL; Liu YJ; McKenney JK; Billings SD; Švajdler M; Koshyk O; Kinkor Z; Michalová K; Kalmykova AV; Yusifli Z; Ptáková N; Hájková V; Grossman P; Šteiner P; Michal M
    Mod Pathol; 2021 Apr; 34(4):770-785. PubMed ID: 33012788
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Primary cutaneous alveolar rhabdomyosarcoma in an adolescent - A challenging diagnosis.
    Calvão J; Cardoso JC; Ramos L; Figueiredo A
    Pediatr Dermatol; 2020 Jan; 37(1):184-186. PubMed ID: 31797424
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. OLIG2 is a novel immunohistochemical marker associated with the presence of PAX3/7-FOXO1 translocation in rhabdomyosarcomas.
    Kaleta M; Wakulińska A; Karkucińska-Więckowska A; Dembowska-Bagińska B; Grajkowska W; Pronicki M; Łastowska M
    Diagn Pathol; 2019 Sep; 14(1):103. PubMed ID: 31493794
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Review of the Role of Cytogenetics in the diagnosis of Orbital Rhabdomyosarcoma.
    Cortes Barrantes P; Jakobiec FA; Dryja TP
    Semin Ophthalmol; 2019; 34(4):243-251. PubMed ID: 31146616
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Rhabdomyosarcoma diagnosed in the first year of life: Localized, metastatic, and relapsed disease. Outcome data from five trials and one registry of the Cooperative Weichteilsarkom Studiengruppe (CWS).
    Sparber-Sauer M; Stegmaier S; Vokuhl C; Seitz G; von Kalle T; Scheer M; Münter M; Bielack SS; Weclawek-Tompol J; Ladenstein R; Niggli F; Ljungman G; Fuchs J; Hettmer S; Koscielniak E; Klingebiel T;
    Pediatr Blood Cancer; 2019 Jun; 66(6):e27652. PubMed ID: 30762282
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pax7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.
    Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A
    Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.